A new Cambridge life-science company aims to develop therapies that can put troublesome genes under the knife, so to speak, cutting out bad DNA like a scalpel excises bad tissue. Cofounders of the company include George Church, HMS professor of genetics and member of the Wyss Institute, and Keith Joung, director of the molecular pathology unit at Massachusetts General Hospital.
